OrthoAccel Technologies, Inc. Announces New Chief Financial Officer
HOUSTON, Dec. 7, 2011 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent™ System, which is an acceleration device to enhance orthodontics, announced a new CFO, Andrew Layman, this week. Mr. Layman began effective December 1, and will oversee all administrative and finance functions at OrthoAccel.
AcceleDent is a simple, removable and non-invasive appliance that a patient wears with braces or aligners in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. The Company announced FDA clearance last month. A randomized, controlled clinical trial conducted at the University of Texas Health Science Center at San Antonio demonstrated, with statistical significance, that tooth movement could be accelerated by 106% during the alignment phase and 38% to 50% during space closure. There was no evidence of incremental root resorption or adverse events, thus demonstrating an excellent safety profile for the appliance.
Mr. Layman joins OrthoAccel as it prepares for its US market launch, amidst growing sales outside of the US. He brings a diverse background that spans international finance, accounting, audit, and tax experience. Mr. Layman is a CPA, and previously spent eight years at a "Big Four" public accounting firm. His operating experience is broad, ranging from start-up to financial responsibility for a $3 billion division at Flextronics Int